Positive news for graphene looking forward; unfortunately, does not make CVV move higher.
CVV stuck in a lower trading range 10-12 instead of break out to new highs over 16.
One has to have great patience holding CVV to one day go 20-25?
Can you go into detail the "bad news".
Did you buy and expect a bounce?
NTLS will be a takeunder no more than $10 as it has some value like S.
No news this year on SS CA - is this project dead and no mother lode?
In other words, is the crew out there to find silver or not.
Can't think of any other event which will make OMEX go over a buck/share.
Looks only going to get you so far...its what inside that counts (lol).
You're trying to imitate and be like Phyllis Diller?
My guess is you didn't average down went IMMR went lower last year under 8.
If you did, your break-even point would have been lower, say in the range of 11-12.
IMMR reminds me of IGT...great company but could not sell the product and get a higher stock price to follow.
IMMR will probably be sold.
This small cap will fit in a bigger company's outfit.
Only question is at what price and will you turn a profit from the sale.
IMMR should see 14+ share price in 2015...will you be happy then?
Revisiting your 5/19/15 message, LNN to announce earnings next couple days.
Stock acting like there is good/positive news coming out and stock up 2+ point to about 85.
EPS should be lower than last year; however, LNN has been perceived to trade like a value stock and small cap. Could be on someone's list to buy.
Don't be surprised if this happens LNN gets an offer over $100/share. Several years ago LNN peaked over $100. A good fit for VMI or TTC.
Another view has it tomorrow all gains today will be taken back.
Irrigation products runs in cycles; expect farmers to soon buy again.
Have you seen any pickup in sales lately?
HIV wonder drug bring in the bucks; GILD has low pe ratio of 13+.
Many wondering what's the next big thing to move GILD stock price to over 150;
Buy a company such as BMY; another wonder drug out there to cure cancer, etc.
Or just stay the course, with expectations pe ratio goes higher 15-18, raising its stock price;
Experts out there?
but now just a shell of itself under GTECH.
Now just a trading stock as of old 12-15 with upside to 18-20.
Wish some great vision leader could lead this stock 25-30, but might be asking too much.
ABBV already made an acquisition and that's enough for now.
ABBV soon to go over 70 and hopefully make it the floor onward to 80 by end of 2015.
The dividend is a bonus along the way.
After reaching 70 it had its pullback/reversal healthy correction.
No negative news on ABBV for awhile (knock on wood)
You are correct, as KYTH will trade flat until deal over.
More cash at 80% and 20% AGN stock is better than all stock for some people but not others. Many prefer to cash out (sell all KYTH) and take their profit, move on. You made at least 50%, no?
When Zillow (Z) bought out Trulia in all stock deal, Trulia lost value as Z stock went over 160 down to under 100 - OUCH. Many sold instead of wait for the merger. That's another stock industry. As a result Trulia went from 75 to about 45.
Go try another biotech company like ZTS rumored consolidation takeover and/or reorganization. Or BMY another potential rumored buyout by PFE or GILD.
Don't think there will be a bidding war for KYTH. Whose out there as Wall Street does not believe another offer coming. Otherwise, KYTH would have traded in the 80s.
$75 is fair price as KYTH has more than doubled.
Don't get greedy.
When the old company Allergan got bought/saved by Actavis, the CEO sold all his shares...made millions and left the company. Check it out.
Actavis this week changed its name to Allergan...good choice for name recognition.
Old company Actavis has been built on acquisition with some companies like Forest Labs and Watson Pharma. Even though KYTH bought for stock instead of cash, AGN stock price should head higher, at least to 350 sometime this year.
Good story of Actavis CEO in Forbes magazine...you should google to read up on it.
This dude is no Ackman who is a corporate raider as some say he is.
Can't go wrong with the S&P500, only issue is it goes up/down 3X S&P500.
You aren't betting on a biopharma drug might pass or fail resulting in double or losing 1/2 your position.
That's why I dollar-cost average UPRO, don't always pick the bottom to buy; always buy and stock goes lower. Just keep dry power available and don't bet the house.
In hindsight, you are lucky to buy in 2009 at about the lows of market recovery of the S&P500. You now have 2 two for one splits in UPRO.
Assume one had 3000 shares bought recently at average cost of 69.
How many would have sold for about a $6k gain?
Would you let it ride, assume UPRO goes higher 75-80 range.
Market correction can't confirmed over, just a knee-jerk reaction to FEDS.
Just want to hear what others would do...reply if interested.
I would tend to agree with you.
Some buy and hold for too long and encounter a round trip instead of taking profits along the way.
All depends on the stock you bought.
GILD in biopharma probably a "buy and hold" since 5 years ago looking back.
I believe it was early 2015 the panic when GILD went to 86-88, but looking back, it was great to buy more.
BTW I also own ABBV and AGN for diversification in pharma.
I am a trader in UPRO (3X S&P500).
Are you guys a day; trader on GILD?
You're following GILD too closely by the minute.
Last week GILD traded prior to ex-divvy at about 112.
Looking for GILD to go 124-125 then go flat trading for several weeks.
Short covering as general market moves higher.
Barron's last year had a write-up mentioned Z whose fair value is in the 70s.
It's getting there, as over 140 Z was over-hyped.
Those who inherited Z through Trulia shareholders screwed.
RAD will most likely be an acquisition target instead of acquiring.
The bad news is it will be a low ball number 10-12.
Long term shareholders screwed.
Does RAD have a chance to trade 15-20 or over?
Interesting point of view for your short-term trading UPRO.
If it works, stay with it.
I been dollar-cost average when the S&P500 goes lower instead of higher; especially dips of more than 10 points.
The assumption is S&P500 is within 10% of its all-time high and should bounce back.
As of Greece and/or default, could be a non-factor even if they default.
However, last minute, expect some kind of deal and everybody happy: to a degree.
When 2015 ends S&P500 should be near 2200.
That makes UPRO near 80 or 75-80 range.
Big picture is stock market still has legs to go higher, as 2007 was a sever pullback to recover from.
Probably only in the 6th inning of the 9 inning game according to a Barron's recent article.
Still not yet time to sell XPO.
XPO should head higher 60-70 late this year or next.
And if more companies added, this will be a positive for XPO.